AI-Powered KRYS Term Structure




KRYS Forecast


Bearish   <—>   Bullish



80% Confidence



Bullish Case: Two registrational reads (KB801, KB803) plus EU launches (Italy/Spain) and Germany pricing clarity could re-rate KRYS. Vyjuvek momentum persists; >$1B cash; pipeline upside. If catalysts land, KRYS could reach 340-360 by year-end, aided by Helium IV skew and strong call flow.



Bearish Case: Regulatory delays, pricing headwinds in Europe, or weaker data for KB803/KB801 could curb upside and push KRYS toward 250-270 by year-end. High tail-risk options imply downside in a negative surprise, while mean-reversion could cap losses.



Potential Outcomes:
  • Base: KRYS stays around 290-310; P=40%.
  • Upside: catalysts land; 320-360; P=25%.
  • Downside: regulatory delays; 260-285; P=20%.
  • Tail: -30% to -60%; P=15%.


May 19, 2026


Krystal Biotech Forecast

KRYS        Krystal Biotech

4 Day Price Forecast + Historical Performance.  (?)

9 Day Price Forecast + Historical Performance.  (?)

20 Day Price Forecast + Historical Performance.  (?)

36 Day Price Forecast + Historical Performance.  (?)

49 Day Price Forecast + Historical Performance.  (?)















Become a more profitable trader with AI optimized trading strategies